Tag Archives: Into

Lured by high demand, Korean wholesaler smuggled Novo’s obesity drug Saxenda into China

Anti-obesity drug Saxenda has been one of Novo Nordisk’s key growth drivers lately—and apparently, a Korean wholesaler noticed. The pharmaceutical middleman allegedly smuggled the popular drug into China, where it’s not yet approved. Korean regulators are investigating the wholesaler for allegedly hawking Saxenda in China, Korea Biomedical Review reported, citing multiple sources. A Novo spokeswoman confirmed to FiercePharma… Read More »

How MedModular Fits Into the New Lower-Cost, High-Quality, Consumer-Enchanted Healthcare World

In American health economics, there’s a demand side and a supply side. On the demand side, we’ve done a poor job trying to nudge patients and consumers toward rational economic decision making, lacking transparency, information symmetry, and basic health literacy. On the supply side, we’ve engaged in a medical arms race allocating capital resources to… Read More »